Erythropoietin is a glycoprotein hormone mainly released by the kidney, which stimulates red blood cell production. However, in sepsis, the mechanisms responsible for the final increase in circulating erythropoietin remain unclear. Seventeen critically ill patients with Simplified Acute Physiologic Score average 66 (range 43 to 103) were included in this study. Ten patients survived and seven died within 28 days. Blood samples obtained at different times were assayed for erythropoietin, cytokine levels and lactate measurements. PCO 2 gap was assessed to detect the presence of gastric mucosal acidosis. Erythropoietin decreased in the patients who survived while it remained high or increased in non-survivors (37±6.5 vs 147±6.7 UI/l respectively, P<0.05). Erythropoietin plasma levels were correlated with IL-6 levels (r=0.84, P<0.05) and TNFa levels (r=0.84, P<0.05). We observed a significant positive relationship between erythropoietin plasma levels and lactate concentrations (r=0.89, P<0.05) and with PCO 2 gap (r=0.9, P<0.05). No correlation was found between erythropoietin concentration and the other parameters. High serum erythropoietin levels in non-survivors were observed with septic shock despite an increase in the levels of proinflammatory cytokines. We found a relationship between erythropoietin concentration and biological markers of tissue hypoperfusion i.e. lactate levels or PCO 2 gap. This relationship could suggest tissue hypoperfusion as the stimulating factor for erythropoietin production in septic shock.
improvement in oxygen delivery include increased cardiac output and increased oxygen-carrying capacity 11 . This occurrence could be enhanced by increased PO 2 or by increased haemoglobin content through either red blood cell transfusion or endogenous erythropoiesis 12, 13 . Limited data have been reported regarding erythropoiesis as a compensatory mechanism for increased metabolic needs in septic shock. Also, a number of inflammatory mediators can interfere with red blood cell formation 14, 15 . TNFa and IL-1 have been shown to suppress the in vitro synthesis of EPO in cell cultures [16] [17] [18] [19] [20] . IL-6 enhances hypoxia-induced EPO production in hepatocytes 3B cell line in a dose-dependent manner [21] [22] [23] . These proinflammatory cytokines are thought to play a major role in the defective production of EPO in certain disorders. Nevertheless, mechanisms responsible for the final increase in circulating EPO, in sepsis, remains unclear.
The aim of this study was to evaluate the mechanisms responsible for the final increase in circulating EPO in septic shock. Ideally, direct measures of regional tissue perfusion should be used to evaluate EPO production, but this has not been performed in humans. Therefore, in patients with septic shock, we Erythropoietin (EPO) is a glycoprotein hormone primarily released by the kidney, which stimulates red blood cell production [1] [2] [3] [4] . In vitro and in vivo evidence suggests that anaemia and hypoxia are the major stimuli for increased EPO production. Diminished arterial oxygen content associated with anaemia or hypoxia is the predominant stimulus for EPO production and results in an exponential increase in EPO synthesis within minutes to hours 5, 6 . EPO synthesis is subjected to regulation by tissue hypoxia with a negative feedback [7] [8] [9] [10] . In septic shock, clinical and haemodynamic evidence of increased oxygen delivery are reported. The compensatory mechanisms of evaluated the relationship between EPO production and biological markers for tissue hypoperfusion, namely lactate levels and PCO 2 gap.
MATERIALS AND METHODS

Patients
The study was approved by the Hospital Ethics Committee and written informed consent was obtained from each patient's closest relative. It included seventeen consecutive patients with septic shock as defined by the American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee 24 . Patients were eligible for entry into the study if they had a definable source of infection and/or positive blood cultures. To be included in the study after optimal volume resuscitation, the patients had to have the following (at baseline): 1) mean arterial pressure (MAP) <60 mmHg, or 2) signs of altered perfusion i.e. oliguria (<30 ml/h) or an increased lactate level 25 . All patients were entered into the study within 24 hours of meeting these criteria.
The severity of illness was assessed according to the SAPS II score within 24 hours of admission to the Medical Intensive Care Unit. Multiple Organ System Failure (MOSF) scores were calculated as described by Bone and co-workers 24 . Patients were followed for 28 days after the start of the study or until death. Excluded from the study were patients with a documented malignant disease (cancer or haematologic malignancy), acquired immunodeficiency syndrome, chronic renal failure (creatinine clearance less than 50 ml/min), chronic hepatic insufficiency, severe chronic obstructive pulmonary disease requiring oxygen therapy, chronic anaemia (iron deficiency, refractory anaemia, and aplastic anaemia), haemolytic anaemia, or prior administration of erythropoietin. Patients received blood transfusion when haemoglobin was lower than 9 g/dl. Base-line characteristics are summarized in Table 1 .
Lactate measurements
For lactate measurements, arterial blood samples were collected in tubes containing fluoride oxalate. Lactate was measured by an enzymatic colorimetric method adapted to our automatic analyser (Biochem Systems, Paris, France) and the upper limit of normal was considered 2 mmol/l.
Cytokine assays
TNFa and IL-6 were determined in duplicate by an immunoenzymatic assay (ELISA) (Beckman Coulter France, Coultronics France). The limits of detection of the assays were 5 pg/ml for TNFa and 6 pg/ml for IL-6. Normal values were 5-12 pg/ml for TNFa and 6-30 pg/ml for IL-6.
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EPO measurement
Erythropoietin concentrations were determined by immunoenzymatic assay (R & D Systems, France). This assay is highly specific and can detect erythropoietin concentrations as low as 0.25 UI /l. The normal values in adults are range between 5-25 UI/l. Blood samples were assayed for EPO measurements at base-line, 2h, 4h, 8h, 12h, 24h, 36h and 48h. Blood samples were immediately frozen and maintained at -80°C until analysis.
Tonometric measurements
The tonometer (catheter TRIP NGS, Tonometrics, Plastimed, France) was inserted nasally and its position confirmed by auscultation over the epigastrium after injection of 50 ml of air into the lumen. The tonometer and the airway sampling line attached to the patient's respiratory tract were connected to an automated gas analyser (Tonocap, Datex, Helsinki, Finland). After the tonometer balloon was filled with air and allowed to equilibrate for 15 minutes, the gas was sampled and measured by infrared spectroscopy. Arterial blood samples were obtained simultaneously with measurement of P a CO 2 to calculate the gastric-to-arterial PCO 2 difference (P (g-a) CO 2 ) or PCO 2 gap. Blood gas values were entered in the computer database using the Tonocap keyboard for the calculation of gastric intramucosal pH (pHi). All patients received an histamine receptor (H2) blocking agent by a continuous infusion (150 mg per day). During the study, nasogastric tubes were not on continuous aspiration and intravenous sodium bicarbonate and enteral feedings were not administered in order to perform all measurements at steady-state. When patients received enteral feedings, it was changed to parenteral nutrition support during the study.
Statistical analysis
Characteristics of patients and haemodynamic data are represented as the mean±SD. IL-6 and TNFa levels, PCO 2 gap values, serum lactate and EPO concentration were calculated for all patients and are expressed as mean±SD. A nonparametric Mann-Whitney U-test was applied to estimate the significance of difference between survivors (S) and non-survivors (NS). Spearman correlations were used to assess associations between two parameters including EPO concentration, cytokines levels, PCO 2 gap values and lactate concentration. A P<0.05 was considered statistically significant.
RESULTS
Baseline characteristics of the patients
Seventeen critically ill patients with septic shock were enrolled. Diagnosis included 10 patients with pneumonia, three with urosepsis, two with endocarditis, one with peritonitis and one with cellulitis. All patients were followed for the entire 28-day study period or until death. All patients were entered into the study within 24 hours of meeting criteria for septic shock. The severity of the illness was confirmed by a high SAPS score at the time of the diagnosis with a mean of 66 (range 43 to 103). Seven of the 17 patients died during their hospitalization in the intensive care unit, all with multiple organ failure. Four patients died on day five and three patients on day 10. The demographic characteristics and severity of disease are shown in Table 1 . Anaemia (Hb <10g/dl) developed in some patients, however no difference was found when comparing non-survivors or survivors (Table 2 ). Baseline levels of biologic parameters are shown in Table 2 .
EPO release
The level of EPO increased in the non-survivors during the observation period and was higher compared to the values in the survivors (Figure 1 ). In the seven non-surviving patients, plasma EPO levels increased towards death. For one of the ten surviving patients who presented pneumonia with septic shock, the serum EPO concentration showed a peak at 24 hours corresponding to bacteraemia. At baseline, EPO levels were increased both in survivors and nonsurvivors. In spite of the limited number of patients included in the study, statistical analysis showed a 
Cytokine release
There were major inter-individual differences in the plasma concentration of IL-6. At baseline, the concentration of IL-6 in the plasma of the nonsurvivors was 2390±580 ng/ml and remained within this range until the end of the study. In survivors, the concentration of IL-6 was lower but not statistically significant when compared with non-survivors. At 48 hours, the IL-6 concentrations were higher in patients who died from refractory shock compared to the survivor patients (NS: 3633±1700ng/ml vs S: 819±510 ng/ml, P<0.05).
At admission, the TNFa concentrations were 73± 25 ng/ml in non-survivors and 67±41 ng/ml in survivors. TNFa concentrations increased in non-survivors and progressively decreased in survivors at 48 hours (NS: 105±8.3 vs S: 30±8.2 ng/ml, P<0.05).
Lactate measurement
In the two groups of patients, lactate concentration increased when compared to normal range (<2 mmol/l). The initial concentration was significantly higher in the non-survivors than in the survivors (NS: 7.2±2.4 mmol/l vs S: 2.8±0.5 mmol/, P<0.05l) ( Table  3) . At 48 hours, non-survivors presented an elevated lactate concentration (NS: 3.9±1 mmol/l vs S: 2± 0.4 mmol/l) ( Table 3) .
Tonometry results
On admission, all patients presented an elevated PCO 2 gap (S: 15±5.3 mmHg vs NS: 27.8±2.4 mmHg, P<0.05) ( Table 3) . After 24 hours, the PCO 2 gap decreased in non-survivors and the value was 25.8± 2.2 mmHg at the 48th hour. In the survivors, PCO 2 gap returned to the normal values at the 48th hour (10±3 mmHg). Also, at 48 hours, the PCO2 gap was significantly higher in the non-survivors compared to survivors ( Table 3) .
Correlations between variables
At admission, Spearman correlation analysis showed a significant correlation between EPO concentrations and the severity of illness: SAPS II r=0.8, P<0.05; OSF score r=0.84, P<0.001 (Table 4 ). EPO plasma levels were correlated with IL-6 levels (r=0.84, P<0.05) and TNFa levels (r=0.84, P<0.05) at any time of the study. We also demonstrated a significant positive relationship between EPO plasma levels and lactate concentrations (r=0.89, P<0.05) and with PCO 2 gap (r=0.9, P<0.05) at all time points. The inverse 
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relationship between the serum EPO and the blood haemoglobin concentrations (r=-0.81, P<0.05) were observed in the survivors at all times. In contrast, the serum EPO concentration was independent from the blood haemoglobin concentration in non-survivors.
DISCUSSION
The primary aim of the present study was to examine the pattern of serum EPO in patients with septic shock and the relationship between EPO concentration and biological markers for tissue hypoperfusion, i.e. lactate levels and PCO2 gap values. Although only a limited group of seventeen patients was studied, the serum EPO concentration was higher in the non-survivors than in the survivors. In parallel, we observed a significant relationship between EPO concentration and severity of illness (SAPS II, MOSF score). These data may extend the findings of other studies as regards the prognostic value of EPO concentrations in critically ill septic patients 26 .
We demonstrated a relationship between EPO levels and biological markers for tissue hypoperfusion namely lactate and PCO2 gap. Gastrointestinal tonometry is considered a clinically applicable approach to detect gut hypoperfusion in critically ill patients 27 . When related to arterial PCO2, the PCO2 gap appears to be useful marker of gut hypoperfusion 28 . Therefore, PCO2 gap detects hypoperfusion, but does not correspond to occurrence of hypoxia at the level of the gastric mucosa 29 . However, there is convincing evidence that a large PCO2 gap is specific for severe mesenteric hypoperfusion. Currently there is no evidence that small changes in PCO2 gap provide reliable estimates of less severe reductions in mesenteric blood flow 30, 31 . Minor changes in PCO2 gap occur after cardiopulmonary bypass and are not necessarily indicative of adverse clinical outcomes or increased gut permeability 32 . In an experimental model, the PCO2 gap appears to be neither sensitive nor specific for mesenteric hypoperfusion 33 . Therefore, increased PCO2 gap could be considered indicative of decreased flow but does not necessarily indicate intestinal mucosal ischaemia or gut injury. In addition, the source of hydrogen ions by parietal cells of the mucous membrane is an additional source of error. Reflux of bicarbonate-rich duodenal fluid and enteral feeding may affect the generation of intraluminal CO2 34 . Despite methodological problems and the poor predictive value of a small PCO2 gap, it is likely that gastric tonometry could prove a useful clinical tool to monitor tissue oxygenation.
Lactic acid production is considered to be correlated with oxygen delivery and the magnitude of tissue hypoxia 35 . Determinations of lactate concentrations have limitations, particularly in septic conditions where the metabolic alterations are complex. Circulating lactate concentrations provide no significant information regarding regional blood flow, but the combination of lactate concentrations and intramucosal pH could be of prognostic value in patients with severe sepsis 36 . In humans, the mechanisms responsible for the EPO production in sepsis remains unclear. Numerous inflammatory mediators could modulate erythropoietin production 37, 38 . In vitro, TNFa and IL-1 have been found to suppress the synthesis of EPO 39 . IL-6 has been shown to stimulate EPO gene expression in the human hepatic cell line 40 . The role of IL-6 has been suggested in the regulation of erythropoietin production in critically ill children with sepsis or septic shock 41 . Hepatocyte cell (Hep 3B) erythropoietin production was greater in the presence of IL-6 alone than in the presence of plasma from patients with sepsis or septic shock. This result is attributable to the presence in sepsis or septic shock of TNF or other mediators with negative regulatory effects on erythropoietin production 21 . These proinflammatory cytokines are thought to play an important role in the inadequate production of EPO in sepsis 42 . These authors concluded that inadequate EPO production may contribute to the development of anaemia in these patients. However, another study has reported an increased EPO production in septic patients despite the presence of proinflammatory cytokines 25 . Our data are in agreement with that reported in the literature. Our immunoassay results have demonstrated that EPO production is not lowered in septic shock despite the increased levels of proinflammatory cytokines and acute renal failure. High EPO production may be due to increased production by the kidney. However, EPO deficiency may be expected in acute, as in chronic, renal failure. Some evidence has already been reported previously as regards involvement of common mechanisms in control the hypoxia and IL-6 dependent induction of the EPO gene [43] [44] [45] . EPO synthesis may represent a compensatory mechanism to improve oxygen delivery. Further studies regarding the regulation of EPO expression by hypoxia and inflammatory mediators are clearly required in patients with septic shock.
Concentrations of plasma EPO and cytokine levels at baseline and at 48 hours in non-survivor and survivor patients with septic shock
In summary, we demonstrated that the EPO levels were not suppressed despite an increase in the levels of proinflammatory cytokines. High serum EPO levels were associated with a poor outcome. We also observed a relationship between EPO levels and biological markers for tissue hypoperfusion i.e. lactate levels and PCO 2 gap. This relationship could suggest tissue hypoperfusion as the stimulus for increased EPO concentrations in critically ill patients with septic shock.
